Supriya Mahajan
Associate Professor in the Department of Medicine, at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo (UB) , Buffalo NY, USA. She did her PhD from the All India Institute of Medical Sciences New Delhi In Endocrinology & Metabolism followed by Post doctoral Training in NeuroImmunology, at Case Western Reserve University, Cleveland Ohio and University at Buffalo. Her research has focused on HIV neuropathogenesis in the context of drug abuse, specifically on BBB integrity and function as it pertains to neuroinflammation .She has developed and validated the 2D and 3D in-vitro human Blood Brain Barrier models that allow evaluation of drug premeability and mechanisms that underlie BBB modulation. These BBB models also allow drug delivery studies and Pharmacokinetic/Pharmacodynamic analysis of potential drug candidates for a variety of neurological diseases. She uses nanotechnology tools for biomedical applications, specifically for delivery of nanotherapeutics to the brain. She has 150 peer reviewed publications to date and continuous research funding both from private foundations and NIH. She is involved in several collaborative research partnerships locally at UB, SUNY Albany and internationally at National AIDS Research Institute, IIT-Delhi, IIT- Bombay, IIT- Kanpur and IIT- BHU, Delhi University in India, and Capital Medical University in Beijing, on several multidisciplinary research projects.
